sglt2 inhibitors vs glp-1 agonists Diabetic Agents, From Metformin to and GLP1 Receptor Agonists: JACC Focus Seminar Cardiovascular benefits of SGLT2 inhibitors
Description
Comparative trials show that long-acting medications (exenatide once weekly, liraglutide, dulaglutide, and semaglutide) provide better glycemic control than short-acting medications (exenatide twice daily and lixisenatide) [90]
The GLP-1 market is projected to exceed 100B USD by 2030
Always consult a qualified healthcare professional before starting any supplement
Lower risks for AF associated with GLP-1RA were consistently observed in subgroups by baseline age, sex, race, BMI, and HbA1c
Incretin-based drugs as potential therapy for neurodegenerative diseases: Current status and perspectives
2007;9(suppl 1):23-31
